GENE ONLINE|News &
Opinion
Blog

2018-03-07|

7 March, 1938: American biologist David Baltimore was born

by GeneOnline
Share To

American biologist David Baltimore (7 March, 1938 – present) is currently the President Emeritus and Robert Andrews Millikan Professor of Biology. After Renato Dulbecco discovered that tumor viruses operate by incorporating their DNA into the DNA of host cells, David Baltimore and Howard Temin – independently of one another – discovered that viruses with genomes consisting of RNA can also be inserted into host cells’ DNA. This takes place through an enzyme known as “reverse transcriptase”. The discovery that the information in RNA can be transferred to DNA meant that the generally accepted rule that genetic information was only transferred in one direction – from DNA to RNA, to protein – had to be modified. This finding led them to the Nobel Prize in Physiology or Medicine in 1975. David Baltimore was only 37 that year.

Reference
https://www.bbe.caltech.edu/content/david-baltimore

Image Source
https://commons.wikimedia.org/wiki/File:Dr._David_Baltimore1.jpg#file

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
R&D
Vaccine Development Has No Limits, the Application Direction of mRNA After the Nobel Prize
2023-10-17
R&D
Bacteriophage Characteristics Could Provide the Key to Tackling Viruses
2022-11-02
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top